FdaApplication
NDA 020527
Identifiers
- fda_app_no: NDA020527
Properties
| Property | Value |
|---|---|
| applicant_name | WYETH PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 1995-11-17 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREMPHASE 14/14 | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG,0.625MG;N/A,5MG | TABLET;ORAL-28 |
| PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG;5MG | TABLET;ORAL-28 |
| PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.3MG;1.5MG | TABLET;ORAL-28 |
| PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG;2.5MG | TABLET;ORAL-28 |
| PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.45MG;1.5MG | TABLET;ORAL-28 |
5 products